A research network focused on the molecular mechanisms behind rare diseases has been launched with $2.3 million from Genome Canada and the Canadian Institutes of Health Research.
The Rare Diseases Models and Mechanisms Network includes basic science researchers studying gene function in model systems and clinician scientists discovering novel disease genes in Canada. It will study the biological mechanisms underlying rare diseases using model organisms such as fruit flies, zebrafish, mice, yeast and worms.
“Our efforts will build on Canada’s proven leadership in rare disease gene discovery through national engagement,” said Phil Hieter, senior scientist at the University of British Columbia, who is one of the leaders of the project.